Who are Northwest Biotherapeutics, Inc.'s main suppliers?

Northwest Biotherapeutics, Inc. (NWBO) key suppliers include: ADVENT-BIOSERVICES-LTD, TOUCAN-HOLDINGS-LLC, Merck & Co., Inc., Merck & Co., Inc.. View the full supplier network at chainsifter.com/chain/NWBO.

What sector is Northwest Biotherapeutics, Inc. in?

Northwest Biotherapeutics, Inc. (NWBO) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

NWBO Supply Chain: Northwest Biotherapeutics, Inc. Supplier List & 7 Relationships

4Suppliers

0Customers

3Debt Items

20Related Chains

Northwest Biotherapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
ADVENT-BIOSERVICES-LTD	ADVENT-BIOSERVICES-LTD	92%	Prior to the acquisition, Advent provided the Company with product development, manufacturing, cryostorage and distribution services for the Company’s DCVax® product platform pursuant to various serv…
TOUCAN-HOLDINGS-LLC	TOUCAN-HOLDINGS-LLC	90%	the acquisition of Advent BioServices Ltd. ("Advent"), a United Kingdom-based contract development and manufacturing organization (CDMO), from Toucan Holdings LLC (the "Seller")
MRK	Merck & Co., Inc.	72%	been developed in 2023. The Company has determined that the smaller prototype will be preferable, to enable more units to fit in each manufacturing lab. Production of the GMP-grade units will be time…
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from NWBO graph: been developed in 2023. The Company has determined that the smaller prototype will be preferable, to enable more units…

Northwest Biotherapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Northwest Biotherapeutics, Inc..

Northwest Biotherapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
NWBO-DEBT-11439	Warrants outstanding: 200000	90%	xbrl warrant detail from xbrl 2025-12-31.
NWBO-DEBT	Debt stack $64.0M	90%	Market cache reports total debt of $64.0M.
NWBO-DEBT-11440	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.

Northwest Biotherapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Northwest Biotherapeutics, Inc..

Northwest Biotherapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
NWBO-OWNER-KELLEHER-FINANCIAL-ADVISORS	KELLEHER FINANCIAL ADVISORS	90%	13F overlay lists KELLEHER FINANCIAL ADVISORS as top holder; 8 tracked holders.

Northwest Biotherapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
MRK	Merck & Co., Inc.	100.00	1	['supplier']
BNBX	BNB Plus Corp.	50.00	2
EVFM	Evofem Biosciences, Inc.	50.00	2
AVIR	Atea Pharmaceuticals, Inc.	50.00	2
IMMP	Immutep Limited	50.00	2
CYTK	Cytokinetics, Incorporated	50.00	2
CBIH	Cannabis Bioscience International Holdings, Inc.	50.00	2
PSNL	Personalis, Inc.	50.00	2
EDSA	Edesa Biotech, Inc.	50.00	2
DYN	Dyne Therapeutics, Inc.	50.00	2
SLS	SELLAS Life Sciences Group, Inc.	50.00	2
ORANY	ORANGE	50.00	2
GYRE	Gyre Therapeutics, Inc.	50.00	2
SDGR	Schrödinger, Inc.	50.00	2
DKS	DICK'S Sporting Goods, Inc.	50.00	2
ADAG	Adagene Inc.	50.00	2
ELAN	Elanco Animal Health Incorporated	50.00	2
CPMV	Mosaic ImmunoEngineering, Inc.	50.00	2
VNDA	Vanda Pharmaceuticals Inc.	50.00	2
EXOZ	eXoZymes, Inc.	50.00	2

Northwest Biotherapeutics, Inc. Supply Chain